Literature DB >> 20439730

MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1.

Massimo Pizzato1.   

Abstract

Optimal infectivity of HIV-1 virions requires synthesis of the HIV-1 regulatory protein Nef in some producer cells but not others. A survey of 18 lymphoid cell lines found that Nef was dispensable in three, each of which harbored gammaretroviruses. Nef-dependent cell lines were rendered Nef-independent by a cell-free supernatant from the independent lines or by transfection of cloned murine leukemia virus (MLV). Analysis of MLV deletion mutations identified glycosylated gag (glycogag) as the factor that rescues Nef-defective HIV-1 virions. Glycogag was also demonstrated to be required for the infectivity of MLV virions produced in lymphoid cells. Direct comparison of Nef and glycogag revealed identical dependence for activity on Env-pseudotype and producer cell type. The two proteins colocalize within cells, and both increase the yield of viral cDNA in target cells. The functional similarity of Nef and glycogag is a compelling example of convergent evolution in which two structurally unrelated proteins provide a function necessary for virion infectivity in lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439730      PMCID: PMC2889076          DOI: 10.1073/pnas.1001554107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  68 in total

1.  Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.

Authors:  C Aiken
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.

Authors:  M E Greenberg; A J Iafrate; J Skowronski
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

3.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

4.  Polypeptides of feline leukemia virus: a glycosylated gag-related protein is released into culture fluids.

Authors:  J C Neil; J E Smart; M J Hayman; O Jarrett
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

5.  The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling.

Authors:  S Arold; P Franken; M P Strub; F Hoh; S Benichou; R Benarous; C Dumas
Journal:  Structure       Date:  1997-10-15       Impact factor: 5.006

6.  Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease.

Authors:  A A Bukovsky; T Dorfman; A Weimann; H G Göttlinger
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses.

Authors:  A Corbin; A C Prats; J L Darlix; M Sitbon
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  The neuroinvasiveness of a murine retrovirus is influenced by a dileucine-containing sequence in the cytoplasmic tail of glycosylated Gag.

Authors:  R Fujisawa; F J McAtee; K Wehrly; J L Portis
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  gag-Related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms.

Authors:  S A Edwards; H Fan
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

10.  The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.

Authors:  M D Miller; M T Warmerdam; I Gaston; W C Greene; M B Feinberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  37 in total

1.  Mouse retroviruses and chronic fatigue syndrome: Does X (or P) mark the spot?

Authors:  Valerie Courgnaud; Jean-Luc Battini; Marc Sitbon; Andrew L Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

2.  HIV: Antiviral action countered by Nef.

Authors:  Christopher Aiken
Journal:  Nature       Date:  2015-09-30       Impact factor: 49.962

3.  The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild.

Authors:  Anke Heigele; Dorota Kmiec; Kerstin Regensburger; Simon Langer; Lukas Peiffer; Christina M Stürzel; Daniel Sauter; Martine Peeters; Massimo Pizzato; Gerald H Learn; Beatrice H Hahn; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2016-09-14       Impact factor: 21.023

4.  HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity.

Authors:  Yoshiko Usami; Heinrich Göttlinger
Journal:  Cell Rep       Date:  2013-10-24       Impact factor: 9.423

5.  The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.

Authors:  Yoshiko Usami; Sergei Popov; Heinrich G Göttlinger
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

6.  Full-Length Glycosylated Gag of Murine Leukemia Virus Can Associate with the Viral Envelope as a Type I Integral Membrane Protein.

Authors:  Tyler Milston Renner; Kasandra Bélanger; Cindy Lam; María Carla Rosales Gerpe; Joanne Eileen McBane; Marc-André Langlois
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

7.  Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.

Authors:  Christine Goffinet; Sarah Schmidt; Christian Kern; Lena Oberbremer; Oliver T Keppler
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

8.  Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.

Authors:  Christelle Brégnard; Alessia Zamborlini; Marjorie Leduc; Philippe Chafey; Luc Camoin; Ali Saïb; Serge Benichou; Olivier Danos; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  Murine Leukemia Virus Glycosylated Gag Reduces Murine SERINC5 Protein Expression at Steady-State Levels via the Endosome/Lysosome Pathway to Counteract SERINC5 Antiretroviral Activity.

Authors:  Sunan Li; Iqbal Ahmad; Jing Shi; Bin Wang; Changqing Yu; Lixin Zhang; Yong-Hui Zheng
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

10.  Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex.

Authors:  Spyridon Stavrou; Takayuki Nitta; Swathi Kotla; Dat Ha; Kunio Nagashima; Alan R Rein; Hung Fan; Susan R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.